🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareWELCOME: Introduce yourself & read the community guidelines Page 11

WELCOME: Introduce yourself & read the community guidelines

Admin Mon, Feb 19, 2024 at 5:20 PM 185 replies 24,631 viewsPage 11 of 20
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Jan 2, 2025 at 5:09 AM#51
julia.endo said:
Worth answering the question that was asked rather than the one behind it.

Adding a me-too, because a thread of one person's experience is not much use. Posting only so the count is not one.

41 14FitDadDave, RunnerRach, TrialNerd_Beth and 38 others
Reply Quote Save Share Report
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
Jan 11, 2025 at 6:20 PM#52
julia.endo said:
Worth answering the question that was asked rather than the one behind it.

Adding the part of the answer the thread has not reached. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

I would rather be corrected than agreed with, if it comes to it.

42 15Dr.RenalNash, LipidDoc_ATL, BariatricNurseD and 39 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Jan 21, 2025 at 7:26 AM#53

One concrete data point for the thread. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

I would rather be corrected than agreed with, if it comes to it.

Last edited: Jan 21, 2025 at 12:26 PM
43 16maya_sedona, stefan_berlin, Dr.EM_Chicago and 40 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
Jan 30, 2025 at 8:26 PM#54

One thing that is still open after julia.endo’s answer:

What did you change at the same time, and can you separate the two now?

44 17RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 41 others
Reply Quote Save Share Report
Dr.EndoIndy
Member
267
1,234
Oct 2024
Indianapolis, IN
Feb 9, 2025 at 9:21 AM#55

Old thread, but it comes up first when you search for this, so it is worth updating. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

Last edited: Feb 9, 2025 at 12:21 PM
45 18SandraNC_45, Dr.EndoIndy, tom_AK and 42 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register